Canada markets closed

Checkpoint Therapeutics, Inc. (CZTA.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
1.7380-0.0440 (-2.47%)
At close: 08:05AM CEST
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
134
103
192
268
1,069
Operating Expenses
Research Development
63,247
43,566
49,825
48,453
16,352
Selling General and Administrative
8,346
8,685
8,700
8,538
7,918
Total Operating Expenses
71,593
52,251
58,525
56,991
24,270
Operating Income or Loss
-71,459
-52,148
-58,333
-56,723
-23,201
Total Other Income/Expenses Net
-7,350
217
-4,451
-
-
Income Before Tax
-71,358
-51,847
-62,624
-56,670
-23,081
Income from Continuing Operations
-71,358
-51,847
-62,624
-56,670
-23,081
Net Income
-71,358
-51,847
-62,624
-56,670
-23,081
Net Income available to common shareholders
-71,358
-51,847
-62,624
-56,670
-23,081
Basic EPS
-4.38
-3.17
-7.09
-7.45
-4.10
Diluted EPS
-4.38
-3.17
-7.09
-7.45
-4.10
Basic Average Shares
14,188
18,742
8,836
7,603
5,583
Diluted Average Shares
14,188
18,742
8,836
7,603
5,583